Prohibits insurance companies from imposing a co-pay for a follow-up visit to refill an opioid prescription initially written for seven days or less.

New York Assembly Bill A05157 amends the insurance law to prohibit insurance companies from imposing any fee, co-payment, co-insurance, deductible, or other condition on insured individuals who require a follow-up visit with a physician to receive a refill of an opioid drug prescription initially written for seven days or less. This prohibition applies only to the first follow-up visit or refill after the initial prescription. The bill aims to ensure that patients do not face financial barriers in accessing necessary opioid medications for pain management.

Prohibits insurance companies from imposing a co-pay for a follow-up visit to refill an opioid prescription initially written for seven days or less.

New York Assembly Bill A05157 amends the insurance law to prohibit insurance companies from imposing any fee, co-payment, co-insurance, deductible, or other condition on insured individuals who require a follow-up visit with a physician to receive a refill of an opioid drug prescription initially written for seven days or less. This prohibition applies only to the first follow-up visit or refill after the initial prescription. The bill aims to ensure that patients do not face financial barriers in accessing necessary opioid medications for pain management.